Víctor Asensi

5.8k total citations
128 papers, 2.3k citations indexed

About

Víctor Asensi is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Víctor Asensi has authored 128 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Infectious Diseases, 42 papers in Epidemiology and 28 papers in Virology. Recurrent topics in Víctor Asensi's work include HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (22 papers) and HIV/AIDS Research and Interventions (22 papers). Víctor Asensi is often cited by papers focused on HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (22 papers) and HIV/AIDS Research and Interventions (22 papers). Víctor Asensi collaborates with scholars based in Spain, United States and Italy. Víctor Asensi's co-authors include J. A. Cartón, Julio Collazos, Eulalia Valle-Garay, Vincent Soriano, A. Hugo Montes, J. A. Maradona, Javier García‐Samaniego, Joshua Fierer, Álvaro Meana and Victoria Álvarez and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Víctor Asensi

120 papers receiving 2.2k citations

Peers

Countries citing papers authored by Víctor Asensi

Since Specialization

Citations

This map shows the geographic impact of Víctor Asensi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Víctor Asensi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Víctor Asensi more than expected).

Fields of papers citing papers by Víctor Asensi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Víctor Asensi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Víctor Asensi. The network helps show where Víctor Asensi may publish in the future.

Co-authorship network of co-authors of Víctor Asensi

This figure shows the co-authorship network connecting the top 25 collaborators of Víctor Asensi. A scholar is included among the top collaborators of Víctor Asensi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Víctor Asensi. Víctor Asensi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Markers of Inflammation and Immune Dysfunction and Non-AIDS Cancer Risk in Adults With HIV 2025 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Rebeca Izquierdo, Alejandro Vallejo, Inés Suárez‐García, (unknown), Félix Gutiérrez, José A. Pérez‐Molina, David Vinuesa García, Juan Macı́as, Antonio Rivero, Julián Olalla, Marta Montero, Víctor Asensi, Santiago Moreno, Inmaculada Jarrín, Marta Rava, (unknown)	0
2	Epidemiological, Clinical and Analytical Features in Lyme Borreliosis Patients Seropositive for Babesia divergens/venatorum 2025 ·Microorganisms ·(unknown), Luís Miguel González, (unknown), Julio Collazos, (unknown), (unknown), (unknown), (unknown), (unknown), Jeremy Gray, Estrella Montero, Víctor Asensi	0
3	No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients 2024 ·Scientific Reports ·Julio Collazos, (unknown), (unknown), Luís Morano, (unknown), Manuel Rodríguez, (unknown), (unknown), Santiago Melón, (unknown), Eulalia Valle-Garay, Víctor Asensi	2
4	Retrospective study of the epidemiological risk and serological diagnosis of human babesiosis in Asturias, Northwestern Spain 2023 ·Parasites & Vectors ·Estrella Montero, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Karita Haapasalo, Julio Collazos, Víctor Asensi, Luís Miguel González	10
5	Iconodiagnosis: Guidelines and recommendations 2023 ·Ethics Medicine and Public Health ·Philippe Charlier, Antonio Perciaccante, Nicolas Kluger, Michael Nerlich, Otto Appenzeller, Simon Donell, Víctor Asensi, Philip A. Mackowiak, (unknown), Raffaella Bianucci	10
6	Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19 2022 ·PLoS ONE ·Julio Collazos, Peré Domingo, (unknown), (unknown), (unknown), Antonio Lalueza, Emilia Roy‐Vallejo, (unknown), (unknown), Jaime Sanz‐Cánovas, Arturo Artero, José Manuel Ramos, (unknown), (unknown), Víctor Asensi, (unknown)	5
7	The TNF-α (–238 G/A) polymorphism could protect against development of severe sepsis 2021 ·Innate Immunity ·A. Hugo Montes, Eulalia Valle-Garay, (unknown), Julio Collazos, Victoria Álvarez, Álvaro Meana, (unknown), J. A. Cartón, Francisco Taboada, Víctor Asensi	11
8	Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21 2020 ·Journal of Clinical Medicine ·(unknown), Esther Vázquez, Yolanda M. Pacheco, (unknown), Maria Jesús Pérez‐Elías, Fernando Dronda, José L. Casado, Ana Moreno, José Manuel Hermida, Carmen Quereda, Asunción Hernando, Francisco Tejerina, Víctor Asensi, Marı́a José Galindo, Manuel Leal, Santiago Moreno, Alejandro Vallejo	16
9	Factors associated with sepsis development in 606 Spanish adult patients with cellulitis 2020 ·BMC Infectious Diseases ·J. Collazos, B De La Fuente, Javier de la Fuente, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ian López‐Cruz, (unknown), (unknown), José Guerra, Arturo Artero, M. Carmen Davó-Blanes, Víctor Asensi	8
10	Hydroxy-chloroquine to treat COVID-19 – infected patients: Some lessons from medical anthropology and history of medicine 2020 ·Ethics Medicine and Public Health ·Philippe Charlier, Simon Donell, Donatella Lippi, (unknown), Víctor Asensi, Antonio Perciaccante, Otto Appenzeller, Raffaella Bianucci	0
11	The N125S polymorphism in the cathepsin G gene (rs45567233) is associated with susceptibility to osteomyelitis in a Spanish population 2019 ·PLoS ONE ·(unknown), (unknown), A. Hugo Montes, J. A. Cartón, Victoria Álvarez, Álvaro Meana, Joshua Fierer, Eulalia Valle-Garay, Víctor Asensi	11
12	Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors 2019 ·PLoS ONE ·Belén Alejos, Inés Suárez‐García, Otilia Bisbal, José Antonio Iribarren, Víctor Asensi, Miguel Górgolas, Roberto Muga, Santiago Moreno, Inmaculada Jarrín, (unknown)	5
13	Cellulitis in adult patients: A large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment 2018 ·PLoS ONE ·Julio Collazos, (unknown), Alicia García, (unknown), (unknown), (unknown), (unknown), (unknown), Ian López‐Cruz, (unknown), (unknown), José Guerra, Arturo Artero, (unknown), Javier de la Fuente, Víctor Asensi	17
14	Factors predictive of relapse in adult bacterial osteomyelitis of long bones. 2018 ·BMC Infectious Diseases ·(unknown), J. Collazos, J. A. Cartón, (unknown), Víctor Asensi	43
15	Efficacy and Tolerability of Darunavir/Ritonavir in Combination with Abacavir/Lamivudine: An Option in Selected HIV-Infected Patients 2013 ·HIV Clinical Trials ·Ignacio de los Santos, (unknown), Eulalia Valencia, Víctor Asensi, Paloma Gijón, V. Moreno, Jorge Vergas, José Ignacio Bernardino	2
16	Course of Liver Fibrosis in HIV-Hepatitis C Virus-Coinfected Patients Depending on the Response to Hepatitis C Therapy 2012 ·AIDS Research and Human Retroviruses ·(unknown), Julio Collazos, (unknown), Víctor Asensi	9
17	Fatal Outcome Due to Sepsis by Mycobacterium Bovis Six Years After BCG Intravesical Instillations 2010 ·Journal of Medical Cases ·(unknown), J.M. Fernández Gómez, (unknown), (unknown), J. Garcı́a Rodrı́guez, (unknown), Víctor Asensi, J. A. Cartón	2
18	No Relationship Between TNF-α Genetic Variants and Combination Antiretroviral Therapy-Related Lipodystrophy Syndrome in HIV Type 1-Infected Patients: A Case-Control Study and a Meta-Analysis 2010 ·AIDS Research and Human Retroviruses ·(unknown), Montserrat Olona, Joaquim Peraire, Consuelo Viladés, (unknown), Peré Domingo, Víctor Asensi, Montserrat Broch, Carmen Aguilar, Miguel López-Dupla, Gerard Aragonès, Graciano García‐Pardo, (unknown), Joan Vendrell, Cristóbal Richart, Francesc Vidal	9
19	Fase no parasítica de Boophilus microplus (Acari: Ixodidae) en condiciones ambientales y de laboratorio en Costa Rica 2007 ·SHILAP Revista de lepidopterología ·Víctor Asensi, (unknown), Juan José Romero	0
20	Treatment of Chronic Hepatitis C in HIV-Infected Patients with Interferon α -2b Plus Ribavirin 2003 ·AIDS Research and Human Retroviruses ·Mayte Pérez‐Olmeda, Vincent Soriano, Víctor Asensi, (unknown), Míriam Romero, Anna S. Ochoa, (unknown), Miguel Santín, Josep M. Guardiola, (unknown), Marina Núñez, Inmaculada Jiménez-Nàcher, Javier García‐Samaniego, (unknown)	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact